Racke MK - Search Results

1

Phase 1 trial of transforming growth factor beta 2 in chronic progressive MS.

Calabresi PA, Fields NS, Maloni HW, Hanham A, Carlino J, Moore J, Levin MC, Dhib-Jalbut S, Tranquill LR, Austin H, McFarland HF, Racke MK. Calabresi PA, et al. Among authors: racke mk. Neurology. 1998 Jul;51(1):289-92. doi: 10.1212/wnl.51.1.289. Neurology. 1998. PMID: 9674825 Clinical Trial.

2

Long-term treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 2.

Racke MK, Sriram S, Carlino J, Cannella B, Raine CS, McFarlin DE. Racke MK, et al. J Neuroimmunol. 1993 Jul;46(1-2):175-83. doi: 10.1016/0165-5728(93)90247-v. J Neuroimmunol. 1993. PMID: 7689586

3

Impaired renal function in progressive multiple sclerosis.

Calabresi PA, Austin H, Racke MK, Goodman A, Choyke P, Maloni H, McFarland HF. Calabresi PA, et al. Among authors: racke mk. Neurology. 2002 Dec 10;59(11):1799-801. doi: 10.1212/01.wnl.0000036618.68674.7a. Neurology. 2002. PMID: 12473777

4

Intravenous antigen administration as a therapy for autoimmune demyelinating disease.

Racke MK, Critchfield JM, Quigley L, Cannella B, Raine CS, McFarland HF, Lenardo MJ. Racke MK, et al. Ann Neurol. 1996 Jan;39(1):46-56. doi: 10.1002/ana.410390108. Ann Neurol. 1996. PMID: 8572666

5

Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1.

Racke MK, Dhib-Jalbut S, Cannella B, Albert PS, Raine CS, McFarlin DE. Racke MK, et al. J Immunol. 1991 May 1;146(9):3012-7. J Immunol. 1991. PMID: 1707929

6

Copolymer-1-induced inhibition of antigen-specific T cell activation: interference with antigen presentation.

Racke MK, Martin R, McFarland H, Fritz RB. Racke MK, et al. J Neuroimmunol. 1992 Mar;37(1-2):75-84. doi: 10.1016/0165-5728(92)90157-g. J Neuroimmunol. 1992. PMID: 1372332

7

Longitudinal study of myelin basic protein-specific T-cell receptors during the course of multiple sclerosis.

Lovett-Racke AE, Martin R, McFarland HF, Racke MK, Utz U. Lovett-Racke AE, et al. Among authors: racke mk. J Neuroimmunol. 1997 Sep;78(1-2):162-71. doi: 10.1016/s0165-5728(97)00097-0. J Neuroimmunol. 1997. PMID: 9307241

8

Age dependence of clinical and pathological manifestations of autoimmune demyelination. Implications for multiple sclerosis.

Smith ME, Eller NL, McFarland HF, Racke MK, Raine CS. Smith ME, et al. Among authors: racke mk. Am J Pathol. 1999 Oct;155(4):1147-61. doi: 10.1016/S0002-9440(10)65218-2. Am J Pathol. 1999. PMID: 10514398 Free PMC article.

9

The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Frohman EM, Goodin DS, Calabresi PA, Corboy JR, Coyle PK, Filippi M, Frank JA, Galetta SL, Grossman RI, Hawker K, Kachuck NJ, Levin MC, Phillips JT, Racke MK, Rivera VM, Stuart WH; Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Frohman EM, et al. Among authors: racke mk. Neurology. 2003 Sep 9;61(5):602-11. doi: 10.1212/01.wnl.0000082654.99838.ef. Neurology. 2003. PMID: 12963748

10

Therapeutic potential of phosphodiesterase type 4 inhibition in chronic autoimmune demyelinating disease.

Sommer N, Martin R, McFarland HF, Quigley L, Cannella B, Raine CS, Scott DE, Löschmann PA, Racke MK. Sommer N, et al. Among authors: racke mk. J Neuroimmunol. 1997 Oct;79(1):54-61. doi: 10.1016/s0165-5728(97)00111-2. J Neuroimmunol. 1997. PMID: 9357447

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

199 results

Search Page